EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Experiences of Self‐Sampling and Future Screening Preferences in Non‐Attenders Who Returned an HPV Vaginal Self‐Sample in the YouScreen Study: Findings From a Cross‐Sectional Questionnaire

Hannah Drysdale iD, Laura A V Marlow iD, Anita Lim iD, Jo Waller iD

Health Expectations · 2024-08 · 27 (4)

DOI: 10.1111/hex.14118 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Health Expectations, online erschienen am 02.07.2024. Verfasst von Hannah Drysdale und 3 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Prevention Group, School of Cancer and Pharmaceutical Sciences, King's College, Faculty of Life Sciences and Medicine, London, UK. Hauptthemen laut MEDLINE: Papillomavirus Infections. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK, University College Hospitals NHS Foundation Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

We assessed experiences of human papillomavirus (HPV) vaginal self‐sampling and future screening preferences in an ethnically and socio‐economically diverse group of women overdue for cervical screening. Setting and Participants A postal questionnaire was embedded in the YouScreen self‐sampling trial in England: 32.5% (2712/8338) of kit completers returned the survey. Kit non‐completers were encouraged to return a questionnaire, but no responses were received. Participants were ethnically diverse (40.3% came from ethnic minority backgrounds), and 59.1% came from the two most deprived quintiles. Differences in confidence in kit completion, trust in the test results and intention to attend a follow‐up test if HPV‐positive were evaluated using Pearson's χ 2 analyses. Binary logistic regression models explored predictors of a future screening choice and preferences for urine versus vaginal self‐sampling.

Results

Most kit‐completers reported high confidence in self‐sampling (82.6%) and high trust in the results (79.9%), but experiences varied by ethnicity and screening status. Most free‐text comments were positive but some reported difficulties using the device, pain or discomfort. Most women would opt for self‐sampling in the future (71.3% vs. 10.4% for a clinician‐taken test) and it was more often preferred by ethnic minority groups, overdue screeners and never attenders. Urine self‐tests were preferred to vaginal tests (41.9% vs. 15.4%), especially among women from Asian, Black or Other Ethnic backgrounds.

Conclusions

Kit‐completers were confident, found the test easy to complete, and trusted the self‐sample results. However, experiences varied by ethnic group and some women highlighted difficulties with the kit. Most women would prefer self‐sampling in the future, but it was not a universal preference, so offering a choice will be important. Patient or Public Contribution We did not have direct patient and public involvement and engagement (PPIE) in the questionnaire design. However, patients and public representatives did input into the design of the YouScreen trial and reviewed the wider study materials (e.g. participant information sheet). Trial Registration This questionnaire study was embedded in the YouScreen trial. The protocol for the YouScreen trial is available at https://www.isrctn.com/ISRCTN12759467 . The National Institute for Health Research 43 Clinical Research Network (NIHR CRN) Central Portfolio Management System (CPMS) ID is 4441934.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Papillomavirus InfectionsHumansFemaleSurveys and QuestionnairesCross-Sectional StudiesAdultMiddle AgedUterine Cervical NeoplasmsVaginal SmearsEnglandEarly Detection of CancerPatient PreferenceSpecimen HandlingSelf CareMass Screening

Stichwörter der Autor:innen

HPV vaginal self‐samplingcervical screeningconfidencescreening non‐attendersscreening preferencestrust

Autor:innen und Institutionen

  • Cancer Prevention Group, School of Cancer and Pharmaceutical Sciences, King's College, Faculty of Life Sciences and Medicine, London, UK.
  • Centre for Cancer Prevention, Screening and Early Diagnosis, Wolfson Institute of Population Health, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK.

ORCID-Profile: Hannah Drysdale, Laura A V Marlow, Anita Lim, Jo Waller

Förderung

  • Cancer Research UK
  • University College Hospitals NHS Foundation Trust

Zitieren

APA

Drysdale, H., Marlow, L. A. V., Lim, A., & Waller, J. (2024). Experiences of Self‐Sampling and Future Screening Preferences in Non‐Attenders Who Returned an HPV Vaginal Self‐Sample in the YouScreen Study: Findings From a Cross‐Sectional Questionnaire. Health Expectations, 27(4). https://doi.org/10.1111/hex.14118

Vancouver

Drysdale H, Marlow LAV, Lim A, Waller J. Experiences of Self‐Sampling and Future Screening Preferences in Non‐Attenders Who Returned an HPV Vaginal Self‐Sample in the YouScreen Study: Findings From a Cross‐Sectional Questionnaire. Health Expectations. 2024;27(4). doi:10.1111/hex.14118

BibTeX
@article{Drysdale2024,
  author = {Drysdale, Hannah and Marlow, Laura A V and Lim, Anita and Waller, Jo},
  title = {Experiences of Self‐Sampling and Future Screening Preferences in Non‐Attenders Who Returned an HPV Vaginal Self‐Sample in the YouScreen Study: Findings From a Cross‐Sectional Questionnaire},
  journal = {Health Expectations},
  year = {2024},
  volume = {27},
  number = {4},
  doi = {10.1111/hex.14118}
}
Kostenlos starten →